MAJ427 wrote: I recently reached out to investor relations and would like to share the response I got.
My main concerns were 1) Is StageZero processing and billing for at least 1,000 Covid tests per day yet? 2) Is Aristotle still launching in Q1 2021? 3) What is the rollout of Aristotle looking like (partners, advertising, etc.)
This is the respone I received back:
Good morning
Thank you for your email. I am unable to give you daily testing numbers on our COVID tests.
I can confirm that Aristotle is on track to launch this quarter as planned. The rollout will include partnerships.
Given that Aristotle is going to be launched with partnerships in place, pre launch advertising isn't necessary. I can tell you that a full post launch marketing effort is being put in place.
Thank you for your continued support.
Cheers Rebecca
I'm quite satisfied with the response I received and am excited for the next few weeks. News of Artistotle is less than one month away!
QUOTE "Pre launch advertising isn't necessary." UNQUOTE
A lot of wonderful things have been accomplished with this company but advertising is not one of them. Show me a company with this many positives currently ongoing that leaves investors guessing on their actual status when a simple NR would calm everyone and boost the sp. We haven't had an update in two months and the sp has fallen from $1.65 to $1.13. When Aristotle comes out and we get a big percentage gain for the day, the resulting sp will be a lot lower starting at $1.13 versus lets say $1.50. I just don't see the logic........